It would be hard to beat 2000 as a major milestone year for scientific achievement and market recognition of genomics as the new frontier. With the human genome sequenced and bioinformatics companies raising big bucks in the capital markets for the first time, the sector sure had a lot to celebrate.
As we head into 2001 the future doesn’t look quite so bright. A recession looms and scientists must now work out loads of kinks in order to realize genomics’ promise. Nevertheless, industry experts are looking forward to another fun year ahead.